Logo

Alpha Teknova, Inc.

TKNO

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellula… read more

Healthcare

Drug Manufacturers—Specialty & Generic

4 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$4.03

Price

+0.50%

$0.02

Market Cap

$215.723m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financial Reports

Key metrics over the past few years and other important metrics. Amounts in USD.

-23.2%

EBITDA Margin

-41.0%

Net Profit Margin

-21.7%

Free Cash Flow Margin

-23.2%

EBITDA Margin

-41.0%

Net Profit Margin

-21.7%

Free Cash Flow Margin
Revenue

$39.801m

+5.5%

1y CAGR

-1.0%

3y CAGR

+2.3%

5y CAGR
Earnings

-$18.220m

+31.9%

1y CAGR

+27.2%

3y CAGR

-75.6%

5y CAGR
EPS

-$0.34

+40.4%

1y CAGR

+40.9%

3y CAGR

-65.1%

5y CAGR
Book Value

$72.650m

$107.625m

Assets

$34.975m

Liabilities

$15.903m

Debt
Debt to Assets

14.8%

-1.4x

Debt to EBITDA
Free Cash Flow

-$10.387m

+23.2%

1y CAGR

+41.5%

3y CAGR

+8.1%

5y CAGR
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases